Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark W Vogel

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Toxicologic Pathology|November 2, 2013
Gastric parietal cell atrophy and depletion after administration of a sphingosine-1-phosphate 1 inhibitorZaher A Radi, Mark W Vogel
Current Heart Failure Reports|December 4, 2010
Novel natriuretic peptides: new compounds and new approachesMark W Vogel, Horng H Chen
Journal of the American College of Cardiology|December 3, 2013
Pre-clinical diastolic dysfunctionSiu-Hin Wan, Mark W Vogel, Horng H Chen
Circulation. Heart Failure|January 27, 2012
The natural history of preclinical diastolic dysfunction: a population-based studyMark W Vogel, Joshua P Slusser, David O Hodge, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Toxicologic Pathology|November 2, 2013
Gastric parietal cell atrophy and depletion after administration of a sphingosine-1-phosphate 1 inhibitorZaher A Radi, Mark W Vogel
Current Heart Failure Reports|December 4, 2010
Novel natriuretic peptides: new compounds and new approachesMark W Vogel, Horng H Chen
Journal of the American College of Cardiology|December 3, 2013
Pre-clinical diastolic dysfunctionSiu-Hin Wan, Mark W Vogel, Horng H Chen
Circulation. Heart Failure|January 27, 2012
The natural history of preclinical diastolic dysfunction: a population-based studyMark W Vogel, Joshua P Slusser, David O Hodge, et al.
Pageof 1